Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001769030 | SCV002002406 | uncertain significance | not provided | 2020-02-11 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002540482 | SCV003454705 | likely benign | Nemaline myopathy 2 | 2023-09-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004040256 | SCV004978560 | uncertain significance | Inborn genetic diseases | 2023-10-25 | criteria provided, single submitter | clinical testing | The c.13767C>A (p.N4589K) alteration is located in exon 93 (coding exon 91) of the NEB gene. This alteration results from a C to A substitution at nucleotide position 13767, causing the asparagine (N) at amino acid position 4589 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |